Approval · Notice of Compliance 4716 · 1996
RENOVA: Notice of Compliance 4716
Issued June 27, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4716
- Date
- June 27, 1996
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Agent for the treatment of photodamaged skin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RENOVA | 02223686 | — |
Medicinal ingredients
- TRETINOIN 0.05 PER